RESUMO
After biliary atresia, the lesions responsible for surgical jaundice in the infant are perforation of the common bile duct, choledochal cyst, bile plug syndrome, and miscellaneous congenital lesions in descending order of frequency. Perforation of the common bile duct commonly presents with an insidious onset of bilious ascites and is best treated by simple peritoneal drainage. Choledochal cyst usually presents later in childhood but presents in infancy if obstruction of the biliary tree is complete or near complete. Excision is the treatment of choice. Any condition leading to alteration in bile composition may cause bile plug syndrome. Spontaneous resolution is the rule: occasionally, intraoperative irrigation is necessary. Most miscellaneous lesions lend themselves to operative correction.
Assuntos
Cisto do Colédoco , Colestase Extra-Hepática , Doenças do Ducto Colédoco , Humanos , Lactente , Recém-Nascido , Icterícia NeonatalRESUMO
The Registry provides information about 904 children with biliary atresia from more than 100 institutions. There was a 1.4 to 1 female predominance; racial distribution was 62% caucasian, 20% black, 11% Hispanic, 4.2% asian, and 1.5% American Indian. Eight hundred sixteen (90%) underwent corrective surgery (median age at operation, 69 days). Intraoperatively, 70% had totally obliterated extrahepatic bile ducts, 22% had patency of the gallbladder and distal common duct, whereas only 8% had "correctable" biliary atresia (proximal duct patency). A variety of reconstructions were used, but the majority of patients had a Roux-en-Y portoenterostomy with or without exteriorization. Follow-up was available for 670 children (74%) with average length of follow-up of 5 years (range, 1 to 16 years). Five-year actuarial survival was 48% following Kasai's operation, but was less than 10% (at 3 years) if no operative correction was done. Survival was unaffected by sex, type of reconstruction, or cholangitis. Predictors of a bad outcome were (1) caucasian race; (2) operative age greater than 60 days; (3) presence of cirrhosis at initial biopsy; (4) totally nonpatent extrahepatic ducts; (5) absent ducts at the level of transection in the liver hilus; and (6) subsequent development of varices or ascites. Identification of factors predictive of the ultimate outcome provide a basis for either continued efforts with management of Kasai's operation or for early referral for liver transplantation.
Assuntos
Atresia Biliar/cirurgia , Sistema de Registros , Fatores Etários , Análise de Variância , Anastomose em-Y de Roux , Atresia Biliar/patologia , Canadá , Colangiografia , Feminino , Hong Kong , Humanos , Lactente , Recém-Nascido , Masculino , México , Portoenterostomia Hepática/métodos , Prognóstico , Grupos Raciais , Procedimentos Cirúrgicos Operatórios/métodos , Taxa de Sobrevida , Estados UnidosRESUMO
Infection with reovirus 3 (Reo-3) has been suggested as the cause of extrahepatic biliary atresia and idiopathic neonatal hepatitis, but confirmation has been lacking. Therefore we have searched for a specific anti-Reo-3 antibody response in the sera of patients with biliary atresia or neonatal hepatitis and for Reo-3 antigens in their hepatobiliary tissues. Sera from 23 infants with extrahepatic biliary atresia, 12 with neonatal hepatitis, 30 age-matched control patients with other liver diseases, and 55 control patients without liver disease were tested by an enzyme-linked immunosorbent assay for total (IgA, IgG, and IgM) anti-Reo-3 antibodies; sera of infants younger than 6 months of age were tested also for IgM anti-Reo-3 antibodies alone. There was no difference between either total or IgM anti-Reo-3 antibody levels in infants with extrahepatic biliary atresia or neonatal hepatitis and levels in control infants. Reo-3 antigens were not detected in the hepatobiliary tissues of 19 infants (18 with biliary atresia, one with neonatal hepatitis) by an immunoperoxidase method that readily demonstrated Reo-3 in control infected HEp-G2 cells. Our data do not support a relationship between neonatal liver diseases and infection with Reo-3.
Assuntos
Antígenos Virais/análise , Atresia Biliar/etiologia , Hepatite/etiologia , Orthoreovirus Mamífero 3/imunologia , Infecções por Reoviridae/complicações , Reoviridae/imunologia , Ensaio de Imunoadsorção Enzimática , Feminino , Hepatite/imunologia , Humanos , Lactente , Recém-Nascido , Fígado/análise , Fígado/imunologia , Masculino , Infecções por Reoviridae/imunologiaAssuntos
Atresia Biliar/cirurgia , Transplante de Fígado , Fatores Etários , Humanos , Lactente , Prognóstico , Doadores de TecidosAssuntos
Colestase/complicações , Doenças do Sistema Nervoso/etiologia , Deficiência de Vitamina E/etiologia , Adolescente , Ácidos e Sais Biliares/sangue , Criança , Pré-Escolar , Doença Crônica , Humanos , Lactente , Exame Neurológico , Estudos Prospectivos , Fatores de Tempo , Vitamina E/sangue , Vitamina E/uso terapêutico , Deficiência de Vitamina E/tratamento farmacológicoRESUMO
Surgical intervention utilizing the Kasai hepatic portoenterostomy has improved the outcome of patients with biliary atresia and provided a population of patients with unique health problems. The clinical course of 21 children followed for three years or longer was reviewed, focusing on their medical management. Ten (47.6%) had successful bile drainage following surgery and experienced a number of specific problems including recurrent cholangitis, nutritional and growth deficiencies, delayed developmental landmarks, portal hypertension, osteomalacia and osteoporosis, and social and psychiatric difficulties. These complications responded to aggressive medical therapy and support. Although the overall three-year survival of this series was 38.1%, in children who were operated upon prior to 2 months of age and in whom the enteric conduit was externalized the three-year survival rate was 66.7%.
Assuntos
Ductos Biliares/anormalidades , Assistência de Longa Duração , Complicações Pós-Operatórias/terapia , Ductos Biliares/cirurgia , Desenvolvimento Infantil , Pré-Escolar , Colangite/terapia , Deficiências do Desenvolvimento/terapia , Seguimentos , Transtornos do Crescimento/terapia , Humanos , Hipertensão Portal/terapia , Lactente , Métodos , Osteomalacia/terapia , Osteoporose/terapia , Estresse PsicológicoRESUMO
It has been suggested that the quantitative estimation of serum alpha-1-fetoprotein may help in distinguishing the neonatal hepatitis syndrome from biliary atresia. We measured the serum AFP concentration in 52 neonates and infants with various hepatobiliary disorders, including neonatal hepatitis syndrome (group I), biliary atresia (group II), and other hepatopathies such as choledochal cyst (group III). The mean serum AFP concentration in patients with neonatal hepatitis was significantly greater than the mean concentration in the other two groups. There was no significant difference between the mean serum AFP concentrations in patients with biliary atresia and in group III patients. Patient age was noted to be an important factor: Serum AFP levels greater than 35 microgram/ml in infants one to four months of age suggpst the diagnosis of neonatal hepatitis syndrome. Serum AFP levels below 10 microgram/ml in infants less than four months of age suggest the diagnosis of biliary atresia or hepatopathies other than neonatal hepatitis. However, the variable and significant overlapping of serum AFP values between 10 and 35 microgram/ml limit the diagnostic value of this test.